Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Chengcheng Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Triple Negative Breast Neoplasms, Naphthoquinones, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Zhejiang University, National Program for Support of Top-notch Young Professionals, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and STAT3 has emerged as an effective drug target for TNBC treatment. Herein, we employed a scaffold-hopping strategy of natural products to develop a series of naphthoquinone-furopiperidine derivatives as novel STAT3 inhibitors. The in vitro assay showed that compound 10g possessed higher antiproliferative activity than Cryptotanshinone and Napabucasin against TNBC cell lines, along with lower toxicity and potent antitumor activity in a TNBC xenograft model. Mechanistically, 10g could inhibit the phosphorylation of STAT3 and the binding affinity was determined by the SPR assay (KD = 8.30 μM). Molecule docking studies suggested a plausible binding mode between 10g and the SH2 domain, in which the piperidine fragment and the terminal hydroxy group of 10g played an important role in demonstrating the success of this evolution strategy. These findings provide a natural product-inspired novel STAT3 inhibitor for TNBC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.
- Institute of Frontier Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Qingdao 266237, China.
ORCID-Profile: Sunliang Cui
Förderung
- Zhejiang University
- National Program for Support of Top-notch Young Professionals
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Huahai Pharmaceutical Co, LtD.
Zitieren
APA
Fan, C., Lou, S., Shen, C., Liao, J., Ni, H., Chen, S., Zhu, Z., Hu, X., Xie, W., Zhao, H., & Cui, S. (2024). Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00872
Vancouver
Fan C, Lou S, Shen C, Liao J, Ni H, Chen S, et al. Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00872
BibTeX
@article{Fan2024,
author = {Fan, Chengcheng and Lou, Shengying and Shen, Chenjun and Liao, Jialing and Ni, Hao and Chen, Siyu and Zhu, Zhihui and Hu, Xueping and Xie, Wei and Zhao, Huajun and Cui, Sunliang},
title = {Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00872}
}
EUVIMED